Kelso Pharma Italy is committed to expanding the reach of Kelso Pharma Group medicines through partnerships with select pharmaceutical companies. The company specialises in developing and supplying specialty, ‘hard-to-make’ medicines, which are made available to patients through licensees across Europe and beyond. Kelso Pharma Italy has over 100 active partnerships and more than 80 granted product registrations.
In October 2025, Velit Biopharma, acquired in November 2023, began trading as ‘Kelso Pharma Italy’, with the business gearing up for further growth across European markets.
The rebranding of Velit Biopharma to Kelso Pharma Italy is a natural next step in the growth story of the business and demonstrates the support from shareholders and the parent company, Kelso Pharma Group.
Want to learn more about Kelso Pharma and our team? Watch the video below from the Kelso Pharma Corporate Day 2025.